ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 23.95 Delayed Data As of 3:59pm ET |  -0.66 / -2.68%Today’s Change | 12.24 Today|||52-Week Range 26.04 | +50.44% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Baker Bros Advisors Lp Director |  Buy | 5/24/2023 | 259,109 | $25.65 | $6.6M | -6.55% |
Baker Bros Advisors Lp Director | Buy | 5/24/2023 | 218,171 | $25.27 | $5.5M | -6.55% |
Baker Bros Advisors Lp Director | Buy | 5/23/2023 | 116,672 | $25.33 | $3.0M | -6.15% |
Baker Bros Advisors Lp Director | Buy | 5/22/2023 | 82,148 | $24.46 | $2.0M | -3.35% |
Baker Bros Advisors Lp Director | Buy | 5/23/2023 | 74,582 | $25.54 | $1.9M | -6.15% |
Baker Bros Advisors Lp Director | Buy | 5/22/2023 | 40,632 | $24.80 | $1.0M | -3.35% |
Baker Bros Advisors Lp Director | Buy | 5/24/2023 | 28,878 | $25.51 | $736.7K | -6.55% |
Baker Bros Advisors Lp Director | Buy | 5/24/2023 | 24,113 | $25.65 | $618.5K | -6.55% |
Baker Bros Advisors Lp Director | Buy | 5/24/2023 | 20,304 | $25.27 | $513.1K | -6.55% |
Schneyer Mark C Chief Financial Officer & Executive Vice President |  Sale | 5/17/2023 | 15,310 | $22.50 | $344.5K | +5.69% |
Page of 8